Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02484407

Ligand	Ligand name	Chain	PDB	Tanimoto
DRA	11-DEOXY-BETA-RHODOMYCIN	A,B	1XDS	0.7
DM5	IDARUBICIN	A,B,D	198D	0.71
DM5	IDARUBICIN	A	1D38	0.71
DM5	IDARUBICIN	A	1D67	0.71
DDI		A	1R4E	0.7
DDI		A	1P96	0.7
HMY	(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione	A,B	3C9W	0.7
ENM	(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE	A	2PNU	0.74
AKV	{3-[(1R,3S)-1,3-DIHYDROXYPENTYL]-4,5,9,10-TETRAHYDROXY-2-ANTHRYL}ACETATE	A,B,C,D	2F99	0.73
BM6	4-[2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-[1,3]DIOXOLAN-2-YL]-BENZOIC ACID	A	1MVC	0.77
BM6	4-[2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-[1,3]DIOXOLAN-2-YL]-BENZOIC ACID	A,C,E,G	1MZN	0.77
2HI	(2S,3R)-2,7-DIHYDROXY-3-(4-HYDROXYPHENYL)-2,3-DIHYDRO-4H-CHROMEN-4-ONE	A	1ZG3	0.71
E3G	ESTRONE BETA-D-GLUCURONIDE	H,L	1CFV	0.77
184	6-[HYDROXY-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTALEN-2-YL)-METHYL]-NAPHTALENE-2-CARBOXYLIC ACID	A	1FCX	0.73
NCZ	2-HYDROXY-7-METHOXY-5-METHYL-NAPHTHALENE-1-CARBOXYLIC ACID MESO-2,5-DIHYDROXY-CYCLOPENT-3-ENYL ESTER	A	1J5I	0.72
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW2	0.72
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW3	0.72
STG	ESTRIOL 3-(B-D-GLUCURONIDE)	H	2BFV	0.76
STG	ESTRIOL 3-(B-D-GLUCURONIDE)	H,L	1BFV	0.76
OX1		H,Y	1LO2	0.71
NOM	7-HYDROXY-5-METHYL-3,3A,5,11B-TETRAHYDRO-1,4-DIOXA-CYCLOPENTA[A]ANTHRACENE-2,6,11-TRIONE	A	1N5V	0.72
AKY		A,B,C,D	2IPI	0.72
DZN	DAIDZIN	A,B,C,D,E,F,G,H	2VLE	0.72
564	6-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTALENE-2-CARBONYL)-NAPHTALENE-2-CARBOXYLIC ACID	A	1FCY	0.71
S1A	SORAPHEN A	A,B	3GID	0.82
S1A	SORAPHEN A	A,B,C	1W96	0.82
AKA	10-DECARBOXYMETHYLACLACINOMYCIN A (DCMAA)	A	1Q0Z	0.7
GGT	Trioxacarcin A	A,B	3C2J	0.7
156	4-[3-OXO-3-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-PROPENYL]-BENZOIC ACID	A	1FCZ	0.71
AKT	10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT)	A	1Q0R	0.72
NGV	METHYL 5,7-DIHYDROXY-2-METHYL-4,6,11-TRIOXO-3,4,6,11-TETRAHYDROTETRACENE-1-CARBOXYLATE	A,B,C,D	2F98	0.71
NGV	METHYL 5,7-DIHYDROXY-2-METHYL-4,6,11-TRIOXO-3,4,6,11-TETRAHYDROTETRACENE-1-CARBOXYLATE	A	1SJW	0.71
7CA	5,7-DIHYDROXY-2-(4-METHOXYPHENYL)-8-(3-METHYLBUTYL)-4-OXO-4H-CHROMEN-3-YL 6-DEOXY-ALPHA-L-MANNOPYRANOSIDE	A	2H44	0.71
MUF	(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid	A,B	3BEJ	0.7
44D	7-[5-(4-AMINO-5-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-4-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY]-6,9,11-TRIHYDROXY-9-(2-HYDROXY-ACETYL)-7,8,9,10-TETRAHYDRO-NAPHTHACENE-5,12-DIONE	A,B	1NAB	0.72
DM4	1-O-DEMETHYL-6-DEOXYDOXORUBICIN	A	1D37	0.71